Outcomes of allogeneic hematopoietic cell transplantation after bispecific antibodies in non-Hodgkin lymphomas.
Bone Marrow Transplant
; 58(11): 1282-1285, 2023 11.
Article
in En
| MEDLINE
| ID: mdl-37626265
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lymphoma, Non-Hodgkin
/
Antibodies, Bispecific
/
Hematopoietic Stem Cell Transplantation
Limits:
Humans
Language:
En
Journal:
Bone Marrow Transplant
Year:
2023
Document type:
Article